NCT05679973

Brief Summary

This study aimed to evaluate the efficacy of polybutester sutures on postoperative complications in lower impacted third molar surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

February 16, 2022

Completed
11 months until next milestone

First Posted

Study publicly available on registry

January 11, 2023

Completed
Last Updated

January 11, 2023

Status Verified

December 1, 2022

Enrollment Period

6 months

First QC Date

February 16, 2022

Last Update Submit

December 24, 2022

Conditions

Keywords

PolybutesterPolypropylenePainEdemaTrismus

Outcome Measures

Primary Outcomes (11)

  • Pain Evaluation

    Patients were requested to mark their pain intensity on a pain assessment form using a visual analoge scale (VAS) ranging between 0 (no pain) to 10 (most severe pain).

    Postoperative 1st day

  • Pain Evaluation

    Patients were requested to mark their pain intensity on a pain assessment form using a visual analoge scale (VAS) ranging between 0 (no pain) to 10 (most severe pain).

    Postoperative 2nd day

  • Pain Evaluation

    Patients were requested to mark their pain intensity on a pain assessment form using a visual analoge scale (VAS) ranging between 0 (no pain) to 10 (most severe pain).

    Postoperative 3rd day

  • Pain Evaluation

    Patients were requested to mark their pain intensity on a pain assessment form using a visual analoge scale (VAS) ranging between 0 (no pain) to 10 (most severe pain).

    Postoperative 5th day

  • Pain Evaluation

    Patients were requested to mark their pain intensity on a pain assessment form using a visual analoge scale (VAS) ranging between 0 (no pain) to 10 (most severe pain).

    Postoperative 7th day

  • Edema evaluation using Facial measurement

    The distance between predetermined facial anatomic landmarks (from the mandibular angle to lateral corner of the eye, from tragus to labial commissura, and from tragus to soft tissue pogonion) which was measured with using thread and millimeter ruler.

    Preoperative

  • Edema evaluation using Facial measurement

    Postoperative edema was evaluated by the distance between predetermined facial anatomic landmarks (from the mandibular angle to lateral corner of the eye, from tragus to labial commissura, and from tragus to soft tissue pogonion) which was measured with using thread and millimeter ruler.

    Postoperative 2nd day

  • Edema evaluation

    Postoperative edema was evaluated by the distance between predetermined facial anatomic landmarks (from the mandibular angle to lateral corner of the eye, from tragus to labial commissura, and from tragus to soft tissue pogonion) which was measured with using thread and millimeter ruler.

    Postoperative 7th day

  • Trismus Evaluation

    Preoperative trismus was evaluated by the maximum distance between the incisive borders of the upper and lower right incisive teeth which were measured with a caliper.

    Preoperative

  • Trismus evaluation

    Postoperative trismus was evaluated by the maximum distance between the incisive borders of the upper and lower right incisive teeth which was measured with a caliper.

    Postoperative 2nd day

  • Trismus evaluation

    Postoperative trismus was evaluated by the maximum distance between the incisive borders of the upper and lower right incisive teeth which was measured with a caliper.

    Postoperative 7th day

Study Arms (2)

Polybutester

EXPERIMENTAL

Polybutester suture is a copolymer of polyglycol terephthalate and polybutylene terephthalate. It is a synthetic, non-resorbable, monofilament suture material. Polybutester is stronger than other monofilaments. Suture memory is poor and packaging does not retain its shape. Therefore, this suture is easier to work with and the knot security is higher. Polybutester suture adapts better to tensile strength than other synthetic sutures. This suture adapts to the increasing wound edema and returns to its original shape when the edema subsides. Also, this suture reduces the risk of hypertrophic scar formation due to its ability to adapt to the edema and changing configuration of a healing wound. It produces better cosmetic results.

Device: Polybutester suture

Polypropylene

ACTIVE COMPARATOR

Polypropylene, used as suture material, is formed by bringing isotactic stereoisomers of a linear hydrocarbon crystalline polymer into sterile monofilament form. Polymer polypropylene is a non-resorbable, synthetic, monofilament suture. It has high compressive strength and low tissue reactivity. It is resistant to infection formation. In general, the ability to close and protect the wound is good. The suture memory is high, therefore it is difficult to use and the knot security is less than other sutures. Allergic reaction due to polypropylene sutures is very rare.

Device: Polypropylene suture

Interventions

After third molar surgery this suture used for primary closure.

Polybutester

After third molar surgery this suture used for primary closure.

Polypropylene

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Any medication until 2 weeks before the operations,
  • Impacted teeth in mesial and horizontal positions and in class 2 and class B according to Pell \& Gregory classification,
  • Asymptomatic impacted teeth.
  • Coming to control and fill in the given and requested forms,
  • Regularly use the given drugs

You may not qualify if:

  • Systemic disease,
  • Smoking,
  • Pregnancy or breastfeeding,
  • Allergy to the drugs to be used in the study,
  • Using any additional medication that may affect the outcome of the study,
  • Post-operative alveolitis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Van Yuzuncu Yil University, Faculty of Dentistry

Van, 65080, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainEdemaTrismus

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSpasmNeuromuscular ManifestationsNervous System Diseases

Study Officials

  • Levent Ciğerim, Assoc.Prof.

    Yuzuncu Yil University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Oral and Maxillofacial Surgery Department

Study Record Dates

First Submitted

February 16, 2022

First Posted

January 11, 2023

Study Start

September 1, 2019

Primary Completion

March 1, 2020

Study Completion

September 1, 2020

Last Updated

January 11, 2023

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations